Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Compliance Checking in the Open Payments Ecosystem

Given the strict legal frameworks which regulate the movements and management of funds, building financial applications typically proves to be prohibitively expensive for small companies. Not only is it the case that understanding legal requirements and building a framework of compliance checks to ensure that such legislation is adhered to is a complex process, but also, service providers such ...

متن کامل

Abstract: The Impact of the Sunshine Act Open Payments Database on Industry Financial Relationships in Plastic Surgery

RESULTS: Our survey generated 404 responses. Regional distribution was as follows: West 9.75%; Midwest 27.8%; Northeast 24.3%; South 37.3%. 46.9% reported having been in practice for at least 20 years. 61.4% reported being in private practice; 26.1% reported having been in academia. Regarding practice size, 32.9% worked in a group practice (3 or more surgeons), 22.4% in partnership, and 23.4% i...

متن کامل

Inconsistencies Between Physician-Reported Disclosures at the AAOS Annual Meeting and Industry-Reported Financial Disclosures in the Open Payments Database.

BACKGROUND The purpose of this study was to determine the rate and type of inconsistencies between disclosures self-reported by physicians at a major academic meeting in the United States and industry-reported disclosures in the Open Payments database for a concordant time period. METHODS Disclosures for every first and last author from the United States with a medical degree of a podium or p...

متن کامل

Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data

BACKGROUND While many new medications may offer advantages over existing drugs, some newer drugs are reformulations of existing products that provide little innovation or incremental benefit while driving up drug costs. Despite the lack of benefit of these medications, prescribers may be motivated by payments made by the pharmaceutical industry. The objective of the study was to determine the a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: JAMA Ophthalmology

سال: 2019

ISSN: 2168-6165

DOI: 10.1001/jamaophthalmol.2019.2456